Ankylosing Spondylitis
Socioeconomic Impact and Prognosis
Classification Criteria
Axial Spondyloarthritis and Ankylosing Spondylitis
Imaging
Etiology and Pathogenesis
Patients with rheumatoid arthritis, PsA, AS ‘stuck in a cycle of long-term opioid use’
Patients with rheumatic diseases demonstrate a high reliance on opioids around the time of diagnosis, and significant numbers of patients were not on appropriate treatment in the year afterward, according to data in Clinical Rheumatology.
Ancient skeleton with RA may suggest ‘we’ve been dealing with these diseases forever’
Archaeologists in Egypt recently discovered evidence of an ancient case of rheumatoid arthritis, potentially filling in the timeline of humanity’s relationship with autoimmune disease.
Satisfaction low with mandatory transition from Humira to biosimilar in New Zealand
Patients reported low overall satisfaction with New Zealand’s mandatory nationwide transition to an adalimumab biosimilar, though most said they are still taking it and appreciated its less-painful injections, according to a study.
Rheumatologists influential in smoking cessation for patients with ankylosing spondylitis
A rheumatologist’s decision to ask about tobacco use may potentially be the leading factor in whether a patient with ankylosing spondylitis quits smoking, according to data published in Cureus.
FDA approves intravenous formulation of secukinumab
The FDA has approved an intravenous formulation of Cosentyx for use in patients with psoriatic arthritis, ankylosing spondylitis and nonradiographic axial spondyloarthritis, according to a press release from Novartis.